KYOTO -- Takara Bio will ramp up its domestic capacity to produce reagents for PCR tests to 8 million specimens a month, eight times more than the current level, as early as this summer.
Coronavirus
Takara Bio to boost domestic capacity of COVID test reagents 8-fold
Japan government to support drugmaker to prevent supply disruption amid pandemic
